Selling a clinic or healthcare business in Singapore

What a buyer is actually underwriting

Healthcare attracts the highest multiples on this site for good reasons. Demand does not follow the economic cycle. Patients return. Payer relationships, once established, are slow to move. A well-run practice with a stable clinical team produces earnings a buyer can forecast with more confidence than almost any other SME category.

All of that is conditional on one thing: the clinicians staying. Strip that away and what remains is a lease, some equipment and a list of names. This is the sector where the gap between a business and a job is at its widest, and where buyers scrutinise it hardest.

How the multiple range is applied

The indicative range is 5x to 8x normalised EBITDA. Normalisation matters unusually much here, because most practices pay their clinician-owners a mixture of salary and profit distribution that bears no relationship to what employing a replacement would cost.

The adjustment a buyer makes is to ask what it would cost to hire a doctor to do the clinical work the owner currently does, at market rates for that specialty, and to charge that against earnings. In a single-doctor practice this can consume most of the reported profit. That is not a trick. It is the honest economics of the situation, and understanding it before you go to market prevents a painful conversation later.

Within the range:

• Clinician continuity. Signed arrangements with the doctors who are staying. This matters more here than any factor in any sector on this site.
• Payer mix. Documented, stable patient volumes across a spread of payers rather than dependence on one panel or corporate contract.
• Licence position. Whether licences transfer with the entity or require fresh application.
• Clinical governance. Clean records, proper documentation, no unresolved incidents.

An illustrative example

Illustrative figures, chosen to show the mechanics.

A two-doctor GP practice turns over S$2.8m with reported profit of S$900,000 after paying the two owner-doctors S$200,000 each. Replacing them at market rates would cost roughly S$300,000 each, so normalisation reduces earnings by S$200,000. Normalised EBITDA is around S$700,000.

At 5x that is roughly S$3.5m, at 8x roughly S$5.6m. Where in that range it lands depends principally on whether the second doctor is staying, and for how long, in writing.

Now run the same arithmetic on a single-doctor practice with S$1.4m revenue and S$500,000 reported profit after a S$180,000 salary. Replacing that doctor costs S$300,000, so normalised EBITDA is closer to S$380,000. And because the doctor is the practice, the deal that gets done is rarely a clean sale at a multiple. It is more often a phased arrangement over two or three years with consideration tied to volumes.

Structure matters more than price here

In most sectors the negotiation is about the number. In healthcare it is at least as much about the structure, and owners who focus only on the headline figure are the ones who end up disappointed.

Three structural questions decide what you actually receive. How long are you committing to stay, and on what terms. How much of the consideration is paid at completion versus deferred against patient volumes or clinician retention. And whether the transaction is a share sale or an asset sale, which drives the licence position, the tax treatment and the timetable.

Settling these early, before a headline price is agreed, gives you far more influence over them than raising them afterwards.

Where to start

Get an indicative range using genuinely normalised earnings, with a market-rate clinical salary charged against profit. It is a less comfortable number than the reported one, and it is the only number a buyer will work from. Then deal with the licence question and clinician continuity, because those two decide the structure. The exit-readiness check scores the ten factors a buyer verifies before pricing.